Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis
Chao Gao(Sichuan University), Yuquan Wei(Sichuan University), Ningyu Wang(Southwest Jiaotong University), Kai Ran(Target (United States)), Yao Shi(Sichuan University), Xinyu You(State Key Laboratory of Biotherapy), Luoting Yu(Sichuan University), Kun Liu(Yantai University), Lidan Zhang(Sichuan University), Yongxia Zhu(University of Electronic Science and Technology of China), Cuiting Peng(Sichuan University), Tinghong Ye(Sichuan University), Lu Xiong(Sichuan University), Weiqiong Zuo(Sichuan University)
Cited by 48
Related Papers
SARS-CoV-2 M <sup>pro</sup> inhibitors with antiviral activity in a transgenic mouse model
|Science|2021|449
Redox homeostasis: the linchpin in stem cell self-renewal and differentiation
|Cell Death and Disease|2013|287
The Anthelmintic Drug Niclosamide Induces Apoptosis, Impairs Metastasis and Reduces Immunosuppressive Cells in Breast Cancer Model
|PLoS ONE|2014|131
Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action
|Molecular Cancer|2009|131
Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2
|Journal of Medicinal Chemistry|2021|116